A representative from the Drug Enforcement Administration (DEA) has expressed the agency’s intention to dispel any misunderstandings surrounding its drug scheduling review process, emphasizing a commitment to transparency. The DEA is currently in the process of potentially reclassifying marijuana and aims to ensure clarity in its decision-making.
Germany has received nearly 900 applications for cannabis cultivation associations, but only just over half…
A Senate stopgap funding bill would delay the federal prohibition on most hemp-derived THC products…
He smokes in boardrooms, but he’s still on that underground frequency. This content originally appeared…
Fox News opinion ran a piece recently from Scott Chipman, vice president of Americans Against…
For our 50th anniversary, we handed the plant to the artists making its most striking…
Corporate valuation increased in 21 of the 38 states studied following medical marijuana legalization. Gross…